Vanguard Capital Management
MBIO icon

Vanguard Capital Management’s Mustang Bio MBIO Stock Holding History

Vanguard Capital Management’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18K Hold
25,704
– – ﹤0.01% 4018
2026
Q1 		$18.7K Buy
+25,704
New +$24.2K ﹤0.01% 3987

Other funds holding MBIO

KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CG
CFO4Life Group Coppell, Texas $743M AUM 25.26% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Vanguard Capital Management's MBIO Position: Q2 2026 in Review

Vanguard Capital Management held its Mustang Bio (MBIO) position steady in Q2 2026 at 25,704 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #4018.

Vanguard Capital Management first reported a position in MBIO in Q1 2026 and has held it in 2 quarters since. The position peaked at $18.7K in Q1 2026. 23 funds tracked by Wall St. Rank hold MBIO as of Q2 2026.

  • Vanguard Capital Management held 25,704 shares of Mustang Bio worth $18K as of Q2 2026.
  • Vanguard Capital Management left its Mustang Bio share count unchanged in Q2 2026.
  • Mustang Bio made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #4018 holding.
  • Vanguard Capital Management first reported a position in Mustang Bio in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Mustang Bio position peaked at $18.7K in Q1 2026.
  • 23 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.